Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

The effects of dependence and function on costs of care for Alzheimer's disease and mild cognitive impairment in Ireland.

Gillespie P, O'Shea E, Cullinan J, Lacey L, Gallagher D, Ni Mhaolain A; B. Lawlor for the Enhancing Care in Alzheimer's Disease (ECAD) Study Team.

Int J Geriatr Psychiatry. 2013 Mar;28(3):256-64. doi: 10.1002/gps.3819. Epub 2012 May 30.

PMID:
23386588
2.

Longitudinal costs of caring for people with Alzheimer's disease.

Gillespie P, O'Shea E, Cullinan J, Buchanan J, Bobula J, Lacey L, Gallagher D, Mhaolain AN, Lawlor B; Enhancing Care in Alzheimer’s Disease (ECAD) Study Team.

Int Psychogeriatr. 2015 May;27(5):847-56. doi: 10.1017/S1041610214002063. Epub 2014 Sep 23.

PMID:
25248030
3.

The effects of patient function and dependence on costs of care in Alzheimer's disease.

Zhu CW, Leibman C, McLaughlin T, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y.

J Am Geriatr Soc. 2008 Aug;56(8):1497-503. doi: 10.1111/j.1532-5415.2008.01798.x. Epub 2008 Jul 24.

4.

Relationship between patient dependence and direct medical-, social-, indirect-, and informal-care costs in Spain.

Darbà J, Kaskens L.

Clinicoecon Outcomes Res. 2015 Jul 2;7:387-95. doi: 10.2147/CEOR.S81045. eCollection 2015.

5.

Determinants of costs of care for patients with Alzheimer's disease.

Jönsson L, Eriksdotter Jönhagen M, Kilander L, Soininen H, Hallikainen M, Waldemar G, Nygaard H, Andreasen N, Winblad B, Wimo A.

Int J Geriatr Psychiatry. 2006 May;21(5):449-59.

PMID:
16676288
6.

Patient dependence and longitudinal changes in costs of care in Alzheimer's disease.

Zhu CW, Leibman C, McLaughlin T, Zbrozek AS, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y.

Dement Geriatr Cogn Disord. 2008;26(5):416-23. doi: 10.1159/000164797. Epub 2008 Oct 22.

7.

Relationship between global severity of patients with Alzheimer's disease and costs of care in Spain; results from the co-dependence study in Spain.

Darbà J, Kaskens L, Lacey L.

Eur J Health Econ. 2015 Nov;16(8):895-905. doi: 10.1007/s10198-014-0642-0. Epub 2014 Oct 28.

PMID:
25348897
8.

Health-related resource use and costs in elderly adults with and without mild cognitive impairment.

Zhu CW, Sano M, Ferris SH, Whitehouse PJ, Patterson MB, Aisen PS.

J Am Geriatr Soc. 2013 Mar;61(3):396-402. doi: 10.1111/jgs.12132. Epub 2013 Feb 15.

9.

Evaluation of full costs of care for patients with Alzheimer's disease in France: the predominant role of informal care.

Gervès C, Chauvin P, Bellanger MM.

Health Policy. 2014 May;116(1):114-22. doi: 10.1016/j.healthpol.2014.01.001. Epub 2014 Jan 8.

PMID:
24461717
10.

Frailty: a costly phenomenon in caring for elders with cognitive impairment.

Butler A, Gallagher D, Gillespie P, Crosby L, Ryan D, Lacey L, Coen R, O'Shea E, Lawlor B.

Int J Geriatr Psychiatry. 2016 Feb;31(2):161-8. doi: 10.1002/gps.4306. Epub 2015 Jul 1.

PMID:
26136186
11.

The economics of mild cognitive impairment.

Lin PJ, Neumann PJ.

Alzheimers Dement. 2013 Jan;9(1):58-62. doi: 10.1016/j.jalz.2012.05.2117. Epub 2012 Nov 8.

PMID:
23141385
12.

The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings.

Wimo A, Reed CC, Dodel R, Belger M, Jones RW, Happich M, Argimon JM, Bruno G, Novick D, Vellas B, Haro JM.

J Alzheimers Dis. 2013;36(2):385-99. doi: 10.3233/JAD-122392.

PMID:
23629588
13.

Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settings.

Reese JP, Hessmann P, Seeberg G, Henkel D, Hirzmann P, Rieke J, Baum E, Dannhoff F, Müller MJ, Jessen F, Geldsetzer MB, Dodel R.

J Alzheimers Dis. 2011;27(4):723-36. doi: 10.3233/JAD-2011-110539.

PMID:
21876256
14.

Clinical characteristics and longitudinal changes of informal cost of Alzheimer's disease in the community.

Zhu CW, Scarmeas N, Torgan R, Albert M, Brandt J, Blacker D, Sano M, Stern Y.

J Am Geriatr Soc. 2006 Oct;54(10):1596-602.

15.

Economic Analysis of Formal Care, Informal Care, and Productivity Losses in Primary Care Patients who Screened Positive for Dementia in Germany.

Michalowsky B, Thyrian JR, Eichler T, Hertel J, Wucherer D, Flessa S, Hoffmann W.

J Alzheimers Dis. 2016;50(1):47-59. doi: 10.3233/JAD-150600.

PMID:
26639964
16.

Costs of care in a mild-to-moderate Alzheimer clinical trial sample: key resources and their determinants.

Gustavsson A, Cattelin F, Jönsson L.

Alzheimers Dement. 2011 Jul;7(4):466-73. doi: 10.1016/j.jalz.2010.06.002.

PMID:
21784355
17.

The cost of Alzheimer's disease in managed care: a cross-sectional study.

Leon J, Neumann PJ.

Am J Manag Care. 1999 Jul;5(7):867-77.

18.

The cost of dementia in Europe: a review of the evidence, and methodological considerations.

Jönsson L, Wimo A.

Pharmacoeconomics. 2009;27(5):391-403. doi: 10.2165/00019053-200927050-00004. Review.

PMID:
19586077
19.

Costs of care for people with dementia just before and after nursing home placement: primary data from eight European countries.

Wübker A, Zwakhalen SM, Challis D, Suhonen R, Karlsson S, Zabalegui A, Soto M, Saks K, Sauerland D.

Eur J Health Econ. 2015 Sep;16(7):689-707. doi: 10.1007/s10198-014-0620-6. Epub 2014 Jul 29.

PMID:
25069577
20.

Caregiver- and patient-directed interventions for dementia: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2008;8(4):1-98. Epub 2008 Oct 1.

Supplemental Content

Support Center